论文部分内容阅读
目的探讨蕲蛇酶预防脑梗塞发生和防止复发的效果。方法一级预防组选择50例高粘滞综合征患者(具备二项以上脑血栓形成因素但未发病者)。二级预防组选择42例各期脑梗雪病者。对以上二组患者均就用蕲蛇酶注射液静滴治疗 ,观察治疗效果并进行五年随访从中分析脑梗塞远期发生率、再发率。结果预防组50我中无一例发生脑梗塞。治疗组42例中有一例于愈后一年、二年分另复发一次 ,一例于愈后二年复发一次 ,余未见复发者。结论蕲蛇酶预防脑血栓形成 ,防止其复发有良好的近期和远期效果
Objective To investigate the effect of Acutobin in preventing cerebral infarction and preventing relapse. Methods Primary prevention group of 50 patients with high-viscosity syndrome (with more than two cerebral thrombosis factors but not onset). Secondary prevention group selected 42 cases of cerebral infarction and snow disease. The above two groups of patients were treated with intravenous infusion of Acuminase, the treatment effect was observed and five-year follow-up analysis of long-term incidence of cerebral infarction, the recurrence rate. Results Prevention Group 50 None of the patients in our study developed cerebral infarction. One of the 42 cases in the treatment group was recovered one year after the second year, another case was relapsed in two years, one case relapsed two years after the cure, and no recurrence was found. Conclusion Acutobin prevent cerebral thrombosis and prevent its recurrence has good short-term and long-term effects